<p>Cartesian Growth Co. II（納斯達克代碼：RENE - 獲取免費報告）在二月份經歷了空頭頭寸的大幅下降。截至 2 月 15 日，空頭頭寸總計為 300 股，較 1 月 31 日的 400 股下降了 25.0%。根據平均每日交易量 9,500 股，目前的覆蓋天數比率為 0.0 天。</p>
<h2>Cartesian Growth Co. II 的機構交易</h2>
<p>機構投資者和對沖基金最近調整了對該股票的持有。Cantor Fitzgerald L. P. 在第四季度購買了價值約 22,125,000 美元的 Cartesian Growth Co. II 的新股份。瑞穗證券美國有限公司在第三季度將其在 Cartesian Growth Co. II 的持股增加了 151.2%。瑞穗證券美國有限公司目前擁有 987,500 股該公司的股票，價值 11,307,000 美元，在此期間又購買了 594,424 股。Westchester Capital Management LLC 在第三季度將其在 Cartesian Growth Co. II 的股份增加了 28.8%。Westchester Capital Management LLC 目前擁有 1,611,362 股該公司的股票，價值 18,466,000 美元，在上個季度又購買了 359,991 股。Crossingbridge Advisors LLC 在第三季度將其在 Cartesian Growth Co. II 的持股增加了 48.6%。Crossingbridge Advisors LLC 目前擁有 790,263 股該公司的股票，價值 9,061,000 美元，在此期間又購買了 258,390 股。最後，Alpine Global Management LLC 在第四季度購買了價值 2,332,000 美元的 Cartesian Growth Co. II 的新頭寸。機構投資者持有該公司 58.96% 的股票。</p>
<h2>Cartesian Growth Co. II 股票表現</h2>
<p>納斯達克：RENE 週一開盤價為 11.73 美元。該股票的 50 日移動平均線為 11.73 美元，200 日移動平均線為 11.59 美元。Cartesian Growth Co. II 的 52 周低點為 11.05 美元，52 周高點為 11.80 美元。</p>
<h2>Cartesian Growth Co. II 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Cartesian Growth Corp. II 作為一家空白支票公司運營。它的成立目的是進行合併、資本股票交換、資產收購、股票購買、重組或與一家或多家企業進行類似的商業組合。該公司成立於 2021 年 10 月 13 日，總部位於紐約，紐約州。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Cartesian Growth Co. II</li>
<li>如何投資生物科技股票</li>
<li>混亂與現金：在波動中尋找機會</li>
<li>你應該將這些沃倫·巴菲特的股票加入你的投資組合嗎？</li>
<li>Realty Income：在波動市場中的錨</li>
<li>投資建築股票</li>
<li>Autodesk 為投資者設計價值：上升趨勢將持續</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Cartesian Growth Co. II 嗎？</h2>
<p>在考慮 Cartesian Growth Co. II 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Cartesian Growth Co. II 並不在名單上。</p>
<p>雖然 Cartesian Growth Co. II 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

RENE

RENEF

<p>Cartesian Growth Co. II (NASDAQ:RENE) 的空頭頭寸截至 2 月 15 日下降了 25%，降至 300 股，覆蓋天數比率為 0.0 天。機構投資者持有該股票的 58.96%，其中瑞穗證券等公司的持股顯著增加。該股票開盤價為 11.73 美元，52 周價格區間為 11.05 美元至 11.80 美元。分析師對其評級為持有，建議其他股票可能是更好的投資選擇</p>

<p>Cartesian Growth Co. II (NASDAQ:RENE - Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 300 shares, a decline of 25.0% from the January 31st total of 400 shares. Based on an average daily volume of 9,500 shares, the days-to-cover ratio is currently 0.0 days.</p>
<div class="lb-trans"><p>Cartesian Growth Co. II（納斯達克代碼：RENE - 獲取免費報告）在二月份經歷了空頭頭寸的大幅下降。截至 2 月 15 日，空頭頭寸總計為 300 股，較 1 月 31 日的 400 股下降了 25.0%。根據平均每日交易量 9,500 股，目前的覆蓋天數比率為 0.0 天。</p>
</div><h2>Institutional Trading of Cartesian Growth Co. II</h2>
<div class="lb-trans"><h2>Cartesian Growth Co. II 的機構交易</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Cantor Fitzgerald L. P. bought a new stake in shares of Cartesian Growth Co. II in the 4th quarter valued at about $22,125,000. Mizuho Securities USA LLC increased its holdings in Cartesian Growth Co. II by 151.2% during the third quarter. Mizuho Securities USA LLC now owns 987,500 shares of the company's stock valued at $11,307,000 after buying an additional 594,424 shares during the period. Westchester Capital Management LLC raised its stake in Cartesian Growth Co. II by 28.8% in the third quarter. Westchester Capital Management LLC now owns 1,611,362 shares of the company's stock worth $18,466,000 after buying an additional 359,991 shares in the last quarter. Crossingbridge Advisors LLC lifted its holdings in Cartesian Growth Co. II by 48.6% during the third quarter. Crossingbridge Advisors LLC now owns 790,263 shares of the company's stock worth $9,061,000 after buying an additional 258,390 shares during the period. Finally, Alpine Global Management LLC purchased a new position in shares of Cartesian Growth Co. II in the 4th quarter valued at $2,332,000. Institutional investors own 58.96% of the company's stock.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近調整了對該股票的持有。Cantor Fitzgerald L. P. 在第四季度購買了價值約 22,125,000 美元的 Cartesian Growth Co. II 的新股份。瑞穗證券美國有限公司在第三季度將其在 Cartesian Growth Co. II 的持股增加了 151.2%。瑞穗證券美國有限公司目前擁有 987,500 股該公司的股票，價值 11,307,000 美元，在此期間又購買了 594,424 股。Westchester Capital Management LLC 在第三季度將其在 Cartesian Growth Co. II 的股份增加了 28.8%。Westchester Capital Management LLC 目前擁有 1,611,362 股該公司的股票，價值 18,466,000 美元，在上個季度又購買了 359,991 股。Crossingbridge Advisors LLC 在第三季度將其在 Cartesian Growth Co. II 的持股增加了 48.6%。Crossingbridge Advisors LLC 目前擁有 790,263 股該公司的股票，價值 9,061,000 美元，在此期間又購買了 258,390 股。最後，Alpine Global Management LLC 在第四季度購買了價值 2,332,000 美元的 Cartesian Growth Co. II 的新頭寸。機構投資者持有該公司 58.96% 的股票。</p>
</div><h2>Cartesian Growth Co. II Stock Performance</h2>
<div class="lb-trans"><h2>Cartesian Growth Co. II 股票表現</h2>
</div><p>NASDAQ:RENE opened at $11.73 on Monday. The stock's fifty day moving average is $11.73 and its 200 day moving average is $11.59. Cartesian Growth Co. II has a fifty-two week low of $11.05 and a fifty-two week high of $11.80.</p>
<div class="lb-trans"><p>納斯達克：RENE 週一開盤價為 11.73 美元。該股票的 50 日移動平均線為 11.73 美元，200 日移動平均線為 11.59 美元。Cartesian Growth Co. II 的 52 周低點為 11.05 美元，52 周高點為 11.80 美元。</p>
</div><h2>Cartesian Growth Co. II Company Profile</h2>
<div class="lb-trans"><h2>Cartesian Growth Co. II 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY.</p>
<div class="lb-trans"><p>Cartesian Growth Corp. II 作為一家空白支票公司運營。它的成立目的是進行合併、資本股票交換、資產收購、股票購買、重組或與一家或多家企業進行類似的商業組合。該公司成立於 2021 年 10 月 13 日，總部位於紐約，紐約州。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Cartesian Growth Co. II</li>
<li>How to Invest in Biotech Stocks</li>
<li>Chaos and Cash: Finding Opportunity in Volatility</li>
<li>Should You Add These Warren Buffett Stocks to Your Portfolio?</li>
<li>Realty Income: An Anchor in Volatile Markets</li>
<li>Investing in Construction Stocks</li>
<li>Autodesk Designs Value for Investors: Uptrend Set to Continue</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Cartesian Growth Co. II</li>
<li>如何投資生物科技股票</li>
<li>混亂與現金：在波動中尋找機會</li>
<li>你應該將這些沃倫·巴菲特的股票加入你的投資組合嗎？</li>
<li>Realty Income：在波動市場中的錨</li>
<li>投資建築股票</li>
<li>Autodesk 為投資者設計價值：上升趨勢將持續</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cartesian Growth Co. II Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Cartesian Growth Co. II 嗎？</h2>
</div><p>Before you consider Cartesian Growth Co. II, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cartesian Growth Co. II 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cartesian Growth Co. II wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Cartesian Growth Co. II 並不在名單上。</p>
</div><p>While Cartesian Growth Co. II currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cartesian Growth Co. II 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Cartesian Growth II (NASDAQ:RENE) 空頭頭寸顯著下降